|
|
| 1. |
Nonsteroidal Anti-Inflammatory Drugs as Risk Factors for Spontaneous Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 34-34
Seppo Juvela,
Preview
|
PDF (21KB)
|
|
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 2. |
Nonsteroidal Anti-Inflammatory Drugs as Risk Factors for Spontaneous Intracerebral Hemorrhage and Aneurysmal Subarachnoid HemorrhageResponse |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 35-36
Søren Johnsen,
Lars Pedersen,
Henrik Sørensen,
Søren Friis,
Jørgen Olsen,
William Blot,
Joseph McLaughlin,
Preview
|
PDF (21KB)
|
|
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 3. |
Dysregulation of the Levels of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in the Early Phase of Cerebral Ischemia |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 37-38
Stefan Lorenzl,
Giovanni De Pasquale,
Alan Segal,
M. Beal,
Preview
|
PDF (28KB)
|
|
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 4. |
Dysregulation of the Levels of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in the Early Phase of Cerebral IschemiaResponse |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 38-38
Mar Castellanos,
José Castillo,
Antoni Dávalos,
Preview
|
PDF (28KB)
|
|
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 5. |
Measuring Cerebral Autoregulation in Stroke PatientsResponse |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 39-40
D. Georgiadis,
R. Baumgartner,
S. Schwarz,
D. Evans,
S. Schwab,
Preview
|
PDF (13KB)
|
|
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 6. |
Symptomatic Carotid Artery Stenosis: Heterogeneity of Destabilizing Mechanisms?Response |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 41-41
Brian Chambers,
Jacinda Stork,
Kazumi Kimura,
Anne Abbott,
Christopher Levi,
Geoffrey Donnan,
Preview
|
PDF (11KB)
|
|
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 7. |
Carotid Angioplasty With Stenting and Carotid Endarterectomy for High-Risk PatientsResponse |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 42-43
D. Fox,
C. Derdeyn,
C. Moran,
D. Cross,
R. Grubb,
R. Dacey,
Preview
|
PDF (13KB)
|
|
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 8. |
“Mobile Stroke Unit” for Hyperacute Stroke Treatment |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 44-44
Klaus Fassbender,
Silke Walter,
Yang Liu,
Frank Muehlhauser,
Andreas Ragoschke,
Sandra Kuehl,
Orell Mielke,
Preview
|
PDF (22KB)
|
|
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 9. |
Oral Anticoagulation in Patients After Cerebral Ischemia of Arterial Origin and Risk of Intracranial Hemorrhage |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 45-46
Preview
|
PDF (37KB)
|
|
摘要:
Background and Purpose—In the recently published Warfarin Aspirin Recurrent Stroke Study (WARSS), a low-intensity anticoagulation regimen was used because of safety concerns. Such concerns are corroborated by the results of the Stroke Prevention in Reversible Ischemia Trial (SPIRIT), which was stopped early because of a high incidence of intracranial hemorrhage with a target international normalized ratio (INR) of 3.0 to 4.5. In the ongoing European/Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT), an intermediate anticoagulation regimen (INR 2.0 to 3.0) is used.Methods—We performed an interim analysis of the incidence of intracranial hemorrhage in ESPRIT.Results—Thus far the overall rate of intracranial hemorrhage is 0.31% (95% CI, 0.18% to 0.52%) per year and 1.21% if all of these were in the anticoagulation group.Conclusions—We conclude that anticoagulation with achieved INR of 2.0 to 3.0 is reasonably safe in patients with cerebral ischemia of arterial origin.
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
| 10. |
Increase in Plasma Matrix Metalloproteinase-9 in Acute Stroke Patients With Thrombolysis Failure |
| |
Stroke: Journal of the American Heart Association,
Volume 34,
Issue 6,
2003,
Page 48-50
Ji Heo,
Seo Kim,
Kyung Lee,
Eun Kim,
Chong Chu,
Jeong Nam,
Preview
|
PDF (64KB)
|
|
摘要:
Background and Purpose—Platelet-rich thrombi are resistant to thrombolytics. Matrix metalloproteinases (MMPs) may be involved in platelet aggregation and contribute to thrombolysis failure in stroke patients.Methods—Plasma samples from 23 stroke patients who had received thrombolytics and from 47 healthy volunteers were examined for MMP-2 and MMP-9 by both enzyme-linked immunosorbent assays and zymography.Results—The arteries were recanalized in 15 patients but not in the other 8. The MMP-9 plasma level was significantly higher in patients whose arteries were not recanalized.Conclusions—MMP-9 may be associated with the formation of a thrombolytics-resistant thrombus.
ISSN:0039-2499
出版商:OVID
年代:2003
数据来源: OVID
|
|
首页
